Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2014
05/06/2014CA2616210C Influenza vaccine compositions
05/06/2014CA2612314C Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers
05/06/2014CA2578449C Novel powder inhalation preparations based on modified lactose blends that are used as adjuvants
05/06/2014CA2534870C Polysaccharide-protein conjugate vaccines
05/06/2014CA2527756C Immunostimulating agents
05/06/2014CA2526150C Treatment of humans with colloidal silver composition
05/06/2014CA2488059C Non-polymeric hematopoietic cell clots for delivery of active agents
05/06/2014CA2401327C Nucleic acid formulations comprising poly-amino acids for gene delivery and methods of use
05/01/2014WO2014066912A1 Polymeric nanoparticles
05/01/2014WO2014066898A1 A layer-by-layer approach to co-deliver dna and sirna via aunps: a potential platform for modifying release kinetics
05/01/2014WO2014066786A1 Affinity peptide-modified particles and targeted drug delivery methods
05/01/2014WO2014066674A1 Amine-functionalized polymeric compositions for medical devices
05/01/2014WO2014066274A1 Alkylated cyclodextrin compositions and processes for preparing and using the same
05/01/2014WO2014066225A1 Low toxicity topical active agent delivery system
05/01/2014WO2014066002A1 Novel self-assembling drug amphiphiles and methods for synthesis and use
05/01/2014WO2014065870A1 Bioadhesive films for local and/or systemic delivery
05/01/2014WO2014065863A1 Compositions and methods for promoting collagen-crosslinking
05/01/2014WO2014065751A1 Lyophilized preparations of melphalan flufenamide
05/01/2014WO2014065661A1 Modified antibody, antibody-conjugate and process for the preparation thereof
05/01/2014WO2014065427A1 Anagliptin-containing solid pharmaceutical preparation
05/01/2014WO2014065390A1 Method for suppressing deposition of menthol whiskers
05/01/2014WO2014065245A1 WEAKLY ACIDIC pH-RESPONSIVE PEPTIDE AND LIPOSOME CONTAINING SAME
05/01/2014WO2014065210A1 Vaccine for preventing porcine edema disease
05/01/2014WO2014064687A1 A system for delivering therapeutic agents into living cells and cells nuclei
05/01/2014WO2014064652A2 Stable pharmaceutical composition of peginterferon alpha-2b
05/01/2014WO2014064574A1 Functionalized hybrid magnetite-gold nanoparticles with core-shell structure
05/01/2014WO2014064424A1 Drug-protein conjugates
05/01/2014WO2014064423A1 Drug-protein conjugates
05/01/2014WO2014064258A1 Compositions and methods for selective delivery of oligonucleotide molecules to cell types
05/01/2014WO2014064257A1 Compositions and methods for the treatment of parkinson disease by the selective delivery of oligonucleotide molecules to specific neuron types
05/01/2014WO2014064196A1 Fibers comprising polyesteramide copolymers for drug delivery
05/01/2014WO2014063757A1 Delivery methods
05/01/2014WO2014063602A1 New drug targeting delivery adjuvant
05/01/2014WO2014063596A1 Oral formulation for treating diabetes
05/01/2014WO2014063549A1 Amphiphilic block copolymer and preparation method thereof and micellar drug-loading system formed by same with antitumor drug
05/01/2014WO2014063253A1 Anti-campylobacter jejuni antibodies and uses therefor
05/01/2014WO2014063178A1 Film coating composition
05/01/2014WO2014038593A3 Granulated material for tablet that rapidly disintegrates in mouth
05/01/2014WO2014033744A3 A novel pharmaceutical composition of linezolid
05/01/2014WO2013186793A9 Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells
05/01/2014WO2013112491A8 Tunable hydrogel materials and methods for preparing the same
05/01/2014WO2013052158A3 Targeted nanovectors and their use for treatment of brain tumors
05/01/2014WO2012134590A3 Calcium supplement
05/01/2014US20140121352 Reversible pegylated drugs
05/01/2014US20140121351 Nucleophilic catalysts for oxime linkage
05/01/2014US20140121283 Methods of using derivatives of (-)-venlafaxine
05/01/2014US20140121260 Novel conjugates of polyunsaturated fatty acids with amines and therapeutic uses thereof
05/01/2014US20140121232 Abuse-deterrent drug formulations
05/01/2014US20140121183 Inhibitors of fatty acid amide hydrolase
05/01/2014US20140121178 Method and improved pharmaceutical composition for improving the absorption of an ester prodrug
05/01/2014US20140121172 Formulations containing labels for medical diagnostics
05/01/2014US20140121169 Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
05/01/2014US20140121161 Repairing bruch's membrane with hydrogels
05/01/2014US20140121159 Terminally–functionalized conjugates and uses thereof
05/01/2014US20140120617 Activation of human antigen-presenting cells through dendritic cell lectin-like oxidized ldl receptor-1 (lox-1)
05/01/2014US20140120191 Method of treating a disorder associated with sequestered bacteria
05/01/2014US20140120171 Therapeutic application of parenteral krill oil
05/01/2014US20140120170 Particles comprising polyesteramide copolymers for drug delivery
05/01/2014US20140120164 Polymer release system
05/01/2014US20140120162 Bioadhesive Drug Delivery Compositions
05/01/2014US20140120158 Compositions and Methods for the Treatment of Parkinson Disease by the Selective Delivery of Oligonucleotide Molecules to Specific Neuron Types
05/01/2014US20140120157 Targeted liposomes
05/01/2014US20140120139 Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
05/01/2014US20140120126 Compositions of hsp60 peptides and viral antigens for vaccination and diagnosis
05/01/2014US20140120120 Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate
05/01/2014US20140120118 Pyrrolobenzodiazepines and conjugates thereof
05/01/2014US20140120081 Use of carbon nanomaterials with antioxidant properties to treat oxidative stress
05/01/2014US20140120078 Fragmented polymeric compositions and methods for their use
05/01/2014US20140120075 Nanozyme Compositions and Methods of Synthesis and Use Thereof
05/01/2014US20140120069 Amphoteric Materials Based on Crosslinked Hyaluronic Acid, Method of Preparation Thereof, Materials Containing Entrapped Active Agents, Method of Preparation Thereof, and Use of Said Materials
05/01/2014US20140120062 Three-dimensional porous biodegradable cell scaffold
05/01/2014US20140120061 Abuse resistant melt extruded formulation having reduced alcohol interaction
05/01/2014US20140120058 Polymer conjugated prostaglandin analogues
05/01/2014US20140120053 Polyesteramide platform for site specific drug delivery
05/01/2014US20140120038 Nanoparticles for imaging and treating chlamydial infection
04/2014
04/30/2014EP2725359A1 Cell separation method using a release system for cell-antibody-substrate conjugates containing a polyethylene glycol spacer unit
04/30/2014EP2725358A1 Release system for cell-antibody-substrate conjugates containing a polyethylene glycol spacer unit
04/30/2014EP2725103A2 Methods and compositions for treating prostate cancer
04/30/2014EP2725053A1 Branched amphipathic block polymer and molecular aggregate and drug delivery system using same
04/30/2014EP2725026A1 Heterocyclic neoflavonoids with taste masking properties
04/30/2014EP2724733A1 Hydrophobic polymer compound having anticoagulant effect
04/30/2014EP2724730A1 Glycoconjugates and their use as potential vaccines against infection by Shigella Flexneri
04/30/2014EP2724718A1 Systems and methods for producing multilayered particles, fibers and sprays and methods for administering the same
04/30/2014EP2724717A1 Surface treatment method for magnetic particles, magnetic composite prepared thereby, and magnetic composite for labeling target materials
04/30/2014EP2724716A1 Phosphodiesterase inhibitors applied via the transvaginal route for the treatment of infertility
04/30/2014EP2724704A1 Method of producing drug-containing wax matrix particles, extruder to be used in the method and sustained-release preparation containing cilostazol
04/30/2014EP2723801A1 New biodegradable polyesteramide copolymers for drug delivery
04/30/2014EP2723800A1 Micro- or nanoparticles comprising a biodegradable polyesteramide copolymer for use in the delivery of bioactive agents
04/30/2014EP2723774A1 Method for manufacturing hydroxyethyl starch derivatives
04/30/2014EP2723773A1 Removal of target cells by circulating virus-specific cytotoxic t-cells using mhc class i comprising complexes
04/30/2014EP2723452A2 Conjugate-based antifungal and antibacterial prodrugs
04/30/2014EP2723439A1 Applicator system for applying a viscous liquid to the human skin
04/30/2014EP2723394A1 Formulations of fluorinated stilbene suitable for pet imaging
04/30/2014EP2723389A2 Novel maytansinoid derivatives with peptide linker and conjugates thereof
04/30/2014EP2723388A1 Controlled release system
04/30/2014EP2723387A1 Cathepsin-binding compounds bound to a carrier and their diagnostic use
04/30/2014EP2723386A1 An aqueous composition comprising a biological antigen and an acrylic acid polymer
04/30/2014EP2723385A1 Film-forming composition, and use thereof for treating herpes
04/30/2014EP2723384A1 Treatment of proteinopathies
04/30/2014EP2723356A1 Delivery of viral agents
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 1712